TrialPloS one2024
Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
Julien Pottecher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
TrialPloS one2024
Julien Pottecher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.